Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 21.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business has a fifty day simple moving average of C$0.10 and a 200-day simple moving average of C$0.07. The firm has a market cap of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Election Stocks: How Elections Affect the Stock Market
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Investing In Preferred Stock vs. Common Stock
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
